FDA Inspection 620031 — China Resources Saike Pharmaceutical Co., Ltd.
The FDA completed an inspection of China Resources Saike Pharmaceutical Co., Ltd. on Jul 23, 2009 in Beijing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 23, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Beijing (China)